ObsEva to Present at Upcoming Investor Conferences
August 03, 2021 01:00 ET
|
ObsEva SA
GENEVA, Switzerland August 3, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 – 12, 2020
August 07, 2020 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – August 7, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s...
Prevail Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Conference
August 05, 2020 16:31 ET
|
Prevail Therapeutics
NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with...
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13-14, 2019
August 09, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – August 9, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization...
iTeos Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference
August 07, 2019 08:00 ET
|
iTeos Therapeutics SA
iTeos Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference Gosselies, Belgium and Cambridge, MA – August 7, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company...